Amgen Partners with Kaléo on Auto-Injector Technology
Kaléo has announced that it has entered into a confidential license agreement with Amgen Inc. under the terms of which Amgen obtained a license to certain of Kaléo's patented technology on auto-injectors.
This agreement reflects Kaléo's innovative contribution to drug-device technologies and its longstanding leadership in advancing patient-centric auto-injector solutions.